0001213900-23-097821.txt : 20231221 0001213900-23-097821.hdr.sgml : 20231221 20231221205445 ACCESSION NUMBER: 0001213900-23-097821 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231221 FILED AS OF DATE: 20231221 DATE AS OF CHANGE: 20231221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Valentine Troy CENTRAL INDEX KEY: 0001998126 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41106 FILM NUMBER: 231506964 MAIL ADDRESS: STREET 1: 105 / 8 CENTURY CIRCUIT CITY: NORWEST, NSW STATE: C3 ZIP: 2153 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Incannex Healthcare Inc. CENTRAL INDEX KEY: 0001873875 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: C3 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 401 DOCKLANDS DRIVE STREET 2: SUITE 15, LEVEL 12 CITY: DOCKLANDS, VICTORIA STATE: C3 ZIP: 3008 BUSINESS PHONE: 61 409 840 786 MAIL ADDRESS: STREET 1: 401 DOCKLANDS DRIVE STREET 2: SUITE 15, LEVEL 12 CITY: DOCKLANDS, VICTORIA STATE: C3 ZIP: 3008 FORMER COMPANY: FORMER CONFORMED NAME: Incannex Healthcare Ltd DATE OF NAME CHANGE: 20210720 4 1 ownership.xml X0508 4 2023-12-21 0 0001873875 Incannex Healthcare Inc. IXHL 0001998126 Valentine Troy 105 / 8 CENTURY CIRCUIT NORWEST, NEW SOUTH WALES C3 2153 AUSTRALIA 1 0 0 0 0 Common Stock 2023-12-21 4 A 0 670000 0 A 699250 D Common Stock 10000 I By Mr. Valentine as the beneficiary of the GFCR Investments Trust Common Stock 30000 I By Valplan Pty Ltd, a company of which Mr. Valentine is a director Common Stock 10000 I By Tranaj Nominees Pty Ltd, a company of which Mr. Valentine is a director Common Stock 242862 I By Alignment Capital Pty Ltd, a company of which Mr. Valentine is a director and major shareholder Common Stock 44400 I By Cityside Pty Ltd, a company wholly-owned by Mr. Valentine Award of restricted stock of which 167,500 shares will vest on December 31, 2023, 167,500 shares concerning the remuneration of fiscal year 2023 will vest on June 30, 2024, 167,500 shares concerning the remuneration of fiscal year 2024 will vest on June 30, 2024, and 167,500 shares will vest on June 30, 2025, based upon the Reporting Person's continuing service as director on each vesting date. /s/ Troy Valentine 2023-12-21